Læknablaðið - 15.03.1996, Page 20

210
LÆKNABLAÐIÐ 1996; 82
brottnámsaðgerð á eista eingöngu læknast 90-
95% sjúklinga með staðbundinn sjúkdóm.
Sjúklingar með meinvörp svara flestir (yfir
90%) meðferð með krabbameinslyfjum eða
geislum og 90% þeirra lifa án sjúkdóms í fjögur
ár frá greiningu (18). Geisla- og lyfjameðferð
hafa ýmsa fylgikvilla, meðal annars aukna tíðni
krabbameina síðar á ævinni og ófrjósemi. Við
teljum að aukið hlutfall yngri karla og hugsan-
lega lægri stigun auki á mikilvægi þess að beita
meðferð með sem fæstum fylgikvillum.
Þakkir
Þakkir fyrir veitta aðstoð fá Egill Jacobsen,
Sverrir Haraldsson og Ólafur Örn Arnarson,
yfirlæknar á þvagfæraskurðdeildum Landspít-
ala, Borgarspítala og Landakotsspítala. Einnig
fær Þórarinn Sveinsson yfirlæknir á krabba-
meinslækningadeild Landspítala sérstakar
þakkir, og sömuleiðis Shree Datye yfirlæknir á
skurðdeild Fjórðungssjúkrahússins á Akur-
eyri, Þorsteinn Gíslason sérfræðingur á Landa-
kotsspítala, Jóhann Heiðar Jóhannsson meina-
fræðingur, Helgi Sigvaldason verkfræðingur
og starfsmenn Krabbameinsskrár Krabba-
meinsfélas íslands. Jónas Magnússon prófess-
or las greinina í handriti og eru honum þakkað-
ar góðar ábendingar. Styrkir til rannsóknar-
innar fengust úr tveimur sjóðum: Vísindasjóði
Landspítalans og Rannsóknarstofu Háskólans
og Minningarsjóði Bergþóru Magnúsdóttur og
Jakobs J. Bjarnasonar.
HEIMILDIR
1. Brodsky GL. Pathology of testicular germ cell tumors.
Hematol/Oncol Clin North Am 1991; 5: 1095-126.
2. Catalona WJ. Current management of testicular tumors.
Surg Clin North Am 1982; 62: 1119-27.
3. Ársskýrsla Krabbameinsfélags fslands 1994. Reykjavík:
Krabbameinsfélag fslands, 1994.
4. Tulinius H, Storm HH, Pukkala E, Andersen A, Er-
icsson J. Cancer in the Nordic Countries, 1981-86. A
joint publication of the five Nordic cancer registries,
1992; 100/SuppI. 31: 88-9.
5. Parkin DM, Muir CS, Whelan SL. Cancer incidence in
five continents. Vol. VI. International agency for re-
search on cancer. Lyon: WHO, 1992.
6. Gudlaugsson E, Magnusson B, Hallgrimsson J. Tu-
mours in Iceland: 13. Malignant tumours of the testis.
APMIS 1990; 98: 173-8.
7. Fraley EE, Lange PH, Kennedy BJ. Germ-cell testicular
cancer in adults. Part II. N Engl J Med 1979; 301:1420-6.
8. Boden G, Gibb R. Radiotherapy and testicular neo-
plasms. Lancet 1951; 2: 1195-7.
9. Kaplan EL, Meier P. Nonparametric estimation from
incomplete observations. J Am Stat Ass 1958; 53: 457-
81.
10. Taron RE. Test for trend in lifetable anaiysis. Biometr-
ika 1975; 62: 679-82.
11. Harpold C, JubelirerSJ. Seminoma: areviewof 15 years
experience. West Virg Med J 1991; 87: 148-51.
12. Kennedy BJ, Schmidt JD, Winchester DP, Peace BL,
Natarajan N, Mettlin C. National survey of patterns of
care for testis cancer. Cancer 1987; 60: 1921-30.
13. Schultz HP, Arends J. Barlebo H, Brincker H, Stryer
CI, Engelholm SA, et al. Testicular carcinoma in Den-
mark 1976-1980. Stage and selected clinical parameters
at presentation. Acta Rad Oncol 1984; 23: 249-53.
14. Hemdal K, Fossá SD, Johansen A. Increasing incidence
and changing stage distribution of testicular carcinoma
in Norway 1970-1987. Br J Cancer 1990; 62: 277-8.
15. Osterlind A. Testikelcancer i Danmark 1943-1982.
Kræftstatistik nr. 14. Ugeskr Læger 1986; 148: 418-21.
16. Whitaker RH. Management of the undescended testis.
Brit J Hosp Med 1970; 4: 25-37.
17. Moul JW. Paulson DF, Dodge RK, Walter PJ. Delay in
diagnosis and survival in testicular cancer: Impact of
effective therapy and changes during 18 years. J Urol
1990; 143: 520-3.
18. Richie JP. Neoplasms of the testis. In: Walsh PC, ed.
Campbell’s Urology. 6th ed. Pennsylvania: Saunders,
1992: 1222-63.
19. Erichsen A. Testikulære germinalcellesvulster - epide-
miologi og risikofactorer. Tidsskr Nor Lægeforen 1990;
110: 2541-3.
20. Babaian RJ, Zagars G. Testicularseminoma: The M.D.
Anderson experience. An analysis of pathological and
patient characteristics, and treatment recommenda-
tions. J Urol 1988; 139: 311-4.
21. Upplýsingarfrá Krabbameinsfélagi fslands,janúar 1995.
22. Thomas GM. Rider WD, Dembo AJ, Cummings BJ,
Gospodarowicz M. Hawkins NV, et al. Seminoma of the
testis: results of treatment and patterns of failure after
radiation therapy. Int J Radiat Oncol Biol Phys 1982; 8:
165-74.
23. van der Werf-Messing B. Radiotherapeutic treatment of
testicular tumors. Int J Radiat Oncol Biol Phys 1976; 1:
235^18.
24. Green N, Broth E, George FW, Kaplan R. Lombardo
L, Skaist L. Radiation therapy in bulky seminoma.
Urology 1983; 21: 467-9.
25. Richie JP. Surgical aspects in the treatment of patients
with testicular cancer. Hematol/Oncol Clin North Am
1991; 5: 1127^12.
26. Pillary G, Rubenstein WA, Siess J. Seminoma. Im-
próved imaging and tumor characterization with com-
puted tomography. J Urol 1980; 123: 41-3.
27. Williams RD, Feinberg SB, Knight LC, Fraley EE. Ab-
dominal staging of testicular tumors using ultrasonog-
raphy and computed tomography. J Urol 1980; 123:
872-5.
28. Dahl O. Testicular carcinoma. A curable malignancy.
Acta Radiol Oncol 1985; 24: 3-15.
29. Einhorn LH, Williams SD. Chemotherapy of dissemi-
nated testicular cancer, a random prospective study.
Cancer 1980; 46: 1339^14.
30. Duchene GM, Horwich A, Dearnaley DP, Nicholls J,
Jay G, Peckham MJ, et al. Orchidectomy alone for stage
I seminoma of the testis. Cancer 1990; 65: 1115-8.
31. Thomas GM. Surveillance in stage I seminoma of the
testis. Urol Clin North Am 1993; 20: 85-91.
32. Jacobsen GK, Mellemgaard A, Möller H. Increased
incidence of sarcoma in patients treated for testicular
seminoma. Eur J Cancer 1993; 29A(5): 664-8.
33. Drasga RE, Einhorn LH. Williams SD. Patel DN, Ste-
vens EE. Fertility after chemotherapy for testicular can-
cer. J Clin Onc 1983; 179-83.